Ownership

Tolga Tanguler

Insider Reports History

Entity: Individual
Location: 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA
Signature: By: Brett Budzinski, Attorney-in-Fact For: Tolga Tanguler
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tolga Tanguler:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
ALNYLAM PHARMACEUTICALS, INC.	EVP, Chief Commercial Officer	Common Stock	28K	$6.93M	$247.35	Mar 3, 2025	Direct
ALNYLAM PHARMACEUTICALS, INC.	EVP, Chief Commercial Officer	Restricted Stock Units	1.67K	$407K	$244.11	Feb 27, 2025	Direct
Lexeo Therapeutics, Inc.	Director	Stock Option (right to buy)	36K			Nov 11, 2024	Direct
ALNYLAM PHARMACEUTICALS, INC.	EVP, Chief Commercial Officer	Stock Option (right to buy)	7.82K			Mar 3, 2025	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Tolga Tanguler

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Mar 3, 2025	8	-$115K	4	Mar 5, 2025	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 27, 2025	10	-$124K	4	Mar 3, 2025	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Nov 25, 2024	6	-$369K	4	Nov 27, 2024	EVP, Chief Commercial Officer
LXEO	Lexeo Therapeutics, Inc.	Nov 11, 2024	1	$0	4	Nov 13, 2024	Director
LXEO	Lexeo Therapeutics, Inc.	Nov 11, 2024	0	$0	3	Nov 13, 2024	Director
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Jun 24, 2024	13	-$371K	4	Jun 26, 2024	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Mar 1, 2024	2	$0	4	Mar 5, 2024	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 27, 2024	7	-$77.8K	4	Feb 29, 2024	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 15, 2024	4	-$149K	4	Feb 20, 2024	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Apr 26, 2023	6	-$287K	4	Apr 28, 2023	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 27, 2023	2	$0	4	Mar 1, 2023	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 1, 2023	11	-$1.16M	4	Feb 3, 2023	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Aug 3, 2022	12	-$1.11M	4	Aug 5, 2022	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Jul 5, 2022	1	-$263K	4	Jul 7, 2022	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 23, 2022	1	$0	4	Feb 25, 2022	EVP, Chief Commercial Officer
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Feb 1, 2022	3	-$220K	4	Feb 3, 2022	EVP, Chief Commercial Officer